Clinical trial

COMbination of Bipolar Androgen Therapy and Nivolumab

NCT03554317

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-09-05

PhasePHASE2

Study timeline

Study start (actual)2018-09-05Date precision: day

Registry last updated2024-02-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Castration-resistant Prostate Cancerunresolved

Metastatic Prostate Cancerunresolved

Prostate Cancerunresolved

Interventions

Testosterone cypionateDRUG · verified · RxNorm: testosterone cypionate

NivolumabDRUG · verified · RxNorm: nivolumab

Sponsors & collaborators

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkinslead sponsor

Bristol-Myers Squibbcollaborator

Mapped research locations

BostonMassachusetts, United States1 BaltimoreMaryland, United States1 San FranciscoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03554317 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.